Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Skovronsky

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Neurosurgery Clinics of North America|June 5, 2004
Pathologic classification of peripheral nerve tumorsDaniel M Skovronsky, John Carl Oberholtzer
Annual Review of Pathology|November 28, 2007
Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implicationsDaniel M Skovronsky, Virginia M-Y Lee, John Q Trojanowski
The Journal of Biological Chemistry|December 14, 2002
Secretion and intracellular generation of truncated Abeta in beta-site amyloid-beta precursor protein-cleaving enzyme expressing human neuronsEdward B Lee, Daniel M Skovronsky, Farhad Abtahian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2015
A Semiautomated Method for Quantification of F 18 Florbetapir PET ImagesAbhinay D Joshi, Michael J Pontecorvo, Ming Lu, et al.
Nuclear Medicine and Biology|October 11, 2011
Sigma receptor binding of tetrabenazine series tracers targeting VMAT2 in rat pancreasHsin-Hsin Tsao, Daniel M Skovronsky, Kun-Ju Lin, et al.
PET Clinics|May 10, 2016
(18)F-AV-133: A Selective VMAT2-binding Radiopharmaceutical for PET Imaging of Dopaminergic NeuronsFranz F Hefti, Hank F Kung, Michael R Kilbourn, et al.
EJNMMI Research|January 10, 2014
Radiation dosimetry of florbetapir F 18Abhinay D Joshi, Michael J Pontecorvo, Lee Adler, et al.
Nuclear Medicine and Biology|May 8, 2010
Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in ratsHsin-Hsin Tsao, Kun-Ju Lin, Jyuhn-Huarng Juang, et al.
Dementia and Geriatric Cognitive Disorders|January 9, 2016
Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use CriteriaMichael Grundman, Keith A Johnson, Ming Lu, et al.
Bioorganic & Medicinal Chemistry Letters|August 19, 2008
Synthesis and evaluation of indolinyl- and indolylphenylacetylenes as PET imaging agents for beta-amyloid plaquesWenchao Qu, Seok-Rye Choi, Catherine Hou, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Neurosurgery Clinics of North America|June 5, 2004
Pathologic classification of peripheral nerve tumorsDaniel M Skovronsky, John Carl Oberholtzer
Annual Review of Pathology|November 28, 2007
Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implicationsDaniel M Skovronsky, Virginia M-Y Lee, John Q Trojanowski
The Journal of Biological Chemistry|December 14, 2002
Secretion and intracellular generation of truncated Abeta in beta-site amyloid-beta precursor protein-cleaving enzyme expressing human neuronsEdward B Lee, Daniel M Skovronsky, Farhad Abtahian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2015
A Semiautomated Method for Quantification of F 18 Florbetapir PET ImagesAbhinay D Joshi, Michael J Pontecorvo, Ming Lu, et al.
Nuclear Medicine and Biology|October 11, 2011
Sigma receptor binding of tetrabenazine series tracers targeting VMAT2 in rat pancreasHsin-Hsin Tsao, Daniel M Skovronsky, Kun-Ju Lin, et al.
PET Clinics|May 10, 2016
(18)F-AV-133: A Selective VMAT2-binding Radiopharmaceutical for PET Imaging of Dopaminergic NeuronsFranz F Hefti, Hank F Kung, Michael R Kilbourn, et al.
EJNMMI Research|January 10, 2014
Radiation dosimetry of florbetapir F 18Abhinay D Joshi, Michael J Pontecorvo, Lee Adler, et al.
Nuclear Medicine and Biology|May 8, 2010
Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in ratsHsin-Hsin Tsao, Kun-Ju Lin, Jyuhn-Huarng Juang, et al.
Dementia and Geriatric Cognitive Disorders|January 9, 2016
Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use CriteriaMichael Grundman, Keith A Johnson, Ming Lu, et al.
Bioorganic & Medicinal Chemistry Letters|August 19, 2008
Synthesis and evaluation of indolinyl- and indolylphenylacetylenes as PET imaging agents for beta-amyloid plaquesWenchao Qu, Seok-Rye Choi, Catherine Hou, et al.
Pageof 4